Opinions of Company Representatives About Neuromodulation

NCT05013827 | Completed

• 1 other identifier: OCEAN
• Study Type: observational
• Target: 39
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this online survey is to gain further insight in the goals, expectations and definition of success for neuromodulation for pain, according to neuromodulation company representatives.

Conditions

Neuromodulation; Pain; Survey

Outcome Measures

Primary Outcomes (3)

• Goals of company representatives, evaluated with a self-constructed question.

  Goals of company representatives to treat patients with neuromodulation for pain.

  Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

• Company representatives expectations, evaluated with a self-constructed question.

  Factors that respondents expect to change according to neuromodulation for pain.

  Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

• Company representatives definition of success of neuromodulation for pain, evaluated with a self-constructed question.

  Company representatives their definition of success of neuromodulation for pain.

  Cross-sectional evaluation during 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris in September.

Study Arms (1)

Company representatives

Behavioral: Filling in an online survey

Interventions

Filling in an online survey BEHAVIORAL

Company representatives are questioned about three aspects: 1) goals in treating patients with neuromodulation for pain, 2) factors that respondents expect to change according to neuromodulation for pain and 3) their definition of success of neuromodulation for pain.

Company representatives

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain as company representatives will be eligible to complete the survey. The survey will be spread at the 2nd Joint Congress of the INS European Chapters (e-INS 2021) in Paris from 2/9/2021 to 4/9/2021.

You may qualify if:

• \- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain as company representatives will be eligible to complete the survey.

You may not qualify if:

• \- Not a company representative.

Sponsors & Collaborators

• Moens Maarten: lead

Study Sites (1)

Vrije Universiteit Brussel

Jette, 1090, Belgium

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: principal investigator

Study Record Dates

• First Submitted: August 4, 2021
• First Posted: August 19, 2021
• Study Start: September 2, 2021
• Primary Completion: September 9, 2021
• Study Completion: September 9, 2021
• Last Updated: January 14, 2022

Record last verified: 2022-01

Locations

BE (1)